Endostatin Enhances Antitumor Effect of Tumor Antigen-Pulsed Dendritic Cell Therapy in Mouse Xenograft Model of Lung Carcinoma

Jing Liang,Xiaolin Liu,Qi Xie,Guoling Chen,Xingyu Li,Yanrui Jia,Beibei Yin,Xun Qu,Yan Li

DOI: https://doi.org/10.21147/j.issn.1000-9604.2016.04.09

2016-01-01

Abstract:Objective: To investigate the antitumor effect of endostatin combined with tumor antigen-pulsed dendritic cell（DC）-T cell therapy on lung cancer.Methods: Transplanted Lewis lung cancer（LLC） models of C57BL/6 mice were established by subcutaneous injection of LLC cells in left extremity axillary. Tumor antigen-pulsed DC-T cells from spleen cells and bone of mice were cultured in vitro. Tumor-bearing mice were randomly divided into three groups, including DCT+endostatin group, DC-T group, and phosphate-buffered saline（PBS） control group. Microvessel density（MVD） of tumor tissue in tumor-bearing mice was determined by immunohistochemistry（IHC）. The expressions of vascular endothelial growth factor（VEGF） and hypoxia-inducible factor-1α（HIF-1α） were determined by Western blotting and IHC staining. The proportions of CD8+ T cells, mature dendritic cells（m DC）, tumor-associated macrophages [TAM（M1/M2）], and myeloid-derived suppressor cells（MDSC） in suspended cells of tumor tissue were determined by flow cytometry. The expressions of interleukin（IL）-6, IL-10, IL-17, transforming growth factor-β（TGF-β） and interferon-γ（IFN-γ） in suspended cells of tumor tissue were detected by enzyme-linked immune sorbent assay（ELISA）.Results: DC-T cells combined with endostatin remarkably suppressed tumor growth. MVD of mice in DCT+endostatin group was significantly lower than that of the control group and DC-T monotherapy group. The expressions of VEGF, IL-6 and IL-17 in tumors were markedly decreased, but IFN-γ and HIF-1α increased after treating with DC-T cells combined with endostatin, compared to control group and DC-T group. In the DCT+endostatin group, the proportions of MDSC and TAM（M2 type） were significantly decreased, m DC and TAM（M1 type） were up-regulated, and CD8+ T cells were recruited to infiltrate tumors, in contrast to PBS control and DC-T monotherapy. DC-T cells combined with endostatin potently reduced the expressions of IL-6, IL-10, TGF-β and IL-17 in tumor tissue, and enhanced the expression of IFN-γ.Conclusions: The study indicated the synergic antitumor effects between endostatin and tumor antigen-pulsed DC-T cells, which may be a prospective therapy strategy to achieve potent antitumor effects on lung cancer.